Atlas Trials

A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites

Clinical trial NCT00660452 · COMPLETED

Trial details

NCT number
NCT00660452
Sponsor
Stallergenes Greer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Allergy
Start date
2007-10-01
Primary completion
2009-07-01
Enrollment
484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.